Abstract
In this chapter, I will describe an application of the proposed platform. Screening of sequential drug combinations will be demonstrated by sequential replacement of the drug chip. PS chips and jig systems developed for robust experiments make it easy to replace the drug chip like LEGO® or inkjet cartridges, and it was the point that partipetting platform is advantageous for this application. Different from other screening technology which needs exponentially increasing number of pipetting as the treatment step increases, only m-step pipetting of DLPs are required for the m-step sequential drug combination treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
S.W. Song et al., One-step generation of a drug-releasing hydrogel microarray-on-a-chip for large-scale sequential drug combination screening. Adv. Sci. 1801380 (2018)
S. Koplev et al., Dynamic rearrangement of cell states detected by systematic screening of sequential anticancer treatments. Cell Rep. 20(12), 2784–2791 (2017)
S. Crystal et al., Patient-derived models of acquired resistance can identify effective drug combinations for cancer. Science 346(6216), 1480–1486 (2014)
M.R. Carstens et al., Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells. Proc. Natl. Acad. Sci. 112(28), 8732–8737 (2015)
D. Miles, G. von Minckwitz, A.D. Seidman, Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist 7(Supplement 6), 13–19 (2002)
R.F. Dear, M.H. Tattersall, K. McGeechan, A. Barratt, N. Wilcken, in Cochrane Database of Systematic Reviews, ed. by R.F. Dear. Combination versus sequential single agent chemotherapy for metastatic breast cancer (Wiley, UK, Chichester, 2010)
F. Cardoso et al., International guidelines for management of metastatic breast cancer: combination vs. sequential single-agent chemotherapy. JNCI J. Natl. Cancer Inst. 101(17), 1174–1181 (2009)
Goldman et al., Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat. Commun. 6, 6139 (2015)
K.M. Eck et al., A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br. J. Cancer 77(12), 2129 (1998)
M. Motwani, T.M. Delohery, G.K. Schwartz, Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res. 5(7), 1876–1883 (1999)
J. Heo et al., Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy. Mol. Ther. 19(6), 1170–1179 (2011)
Z. Dudek, J. Zolnierek, A. Dham, B.R. Lindgren, C. Szczylik, Sequential therapy with sorafenib and sunitinib in renal cell carcinoma. Cancer 115(1), 61–67 (2009)
M.J. Lee et al., Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 149(4), 780–794 (2012)
R.F. Dear, K. McGeechan, M.C. Jenkins, A. Barratt, M.H. Tattersall, N. Wilcken, Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database Syst. Rev. (12)
B. Al-Lazikani, U. Banerji, P. Workman, Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol. 30(7), 679–692 (2012)
H.-H. Wong et al., Drug screening of cancer cell lines and human primary tumors using droplet microfluidics. Sci. Rep. (2017)
M.R. Carstens et al., Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells. Proc. Natl. Acad. Sci. U. S. A. 112(28), 8732–8737 (2015)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Song, S.W. (2019). Application: Screening of Sequential Drug Combinations. In: One-Step Generation of a Drug-Releasing Microarray for High-Throughput Small-Volume Bioassays. Springer Theses. Springer, Singapore. https://doi.org/10.1007/978-981-13-8094-5_3
Download citation
DOI: https://doi.org/10.1007/978-981-13-8094-5_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8093-8
Online ISBN: 978-981-13-8094-5
eBook Packages: EngineeringEngineering (R0)